Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

Elitek

Drug Oncology

NDC 0024-5151-75

Open in the dashboard

General payments

$779,975

4,457 payments

Research payments

$1,090

2 payments

Through program year 2019, $779,975 in general payments and $1,090 in research payments were reported against Elitek (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $779,975 4,457
2019 Research $1,090 2

Breakdown

Who paid General payments · program year 2019
  1. Genzyme Corporation $724,775 4,218 payments
  2. Bioverativ Therapeutics Inc. $47,377 48 payments
  3. Sanofi-Aventis U.S. LLC $7,822 191 payments
Top recipients General payments · program year 2019
  1. Tariq Mughal Hematology & Oncology · Worcester, MA $139,946 18% · 97 payments
  2. Javier Pinilla-Ibarz Hematology · Tampa, FL $31,415 4% · 19 payments
  3. Karen Seiter Hematology & Oncology · Hawthorne, NY $30,462 4% · 18 payments
  4. Omotayo Fasan Hematology · Charlotte, NC $24,965 3% · 17 payments
  5. Jonathan Abbas Hematology & Oncology · Nashville, TN $23,926 3% · 33 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $455,609 64% · 1,394 practitioners
  2. Hematology Internal Medicine $123,478 17% · 71 practitioners
  3. Medical Oncology Internal Medicine $52,821 7% · 421 practitioners
  4. Pediatric Hematology-Oncology Pediatrics $28,767 4% · 11 practitioners
  5. Nephrology Internal Medicine $20,464 3% · 8 practitioners

The top 5 of 44 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Massachusetts $140,052 18% · 5 recipients
  2. California $95,938 12% · 302 recipients
  3. North Carolina $70,842 9% · 59 recipients
  4. Florida $61,181 8% · 252 recipients
  5. New York $44,356 6% · 141 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

4,457 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record